NFE
New Fortress Energy Inc.
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
Company reporting grounded in filings, official releases and clearly dated documents.
Data as of 10-08-2026
Company & ETF research
Covered names add reporting, results and source context. The broader catalog helps you find a filing even when TickerGrove has not written a full research file.
Editorial focus
Names the desk is covering now. Not a popularity ranking and not inferred from quotes.
Featured research
166–180 of 260
NFE
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
NOBH
TickerGrove reporting and official SEC filings.
OTC · SEC-verified identity
NSPR
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
NTAP
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
NTLA
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
NUAI
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
NVS
TickerGrove reporting and official SEC filings.
NYSE · SEC-verified identity
NVT
TickerGrove reporting and official SEC filings.
NYSE · SEC-verified identity
NYAX
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
OCC
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
OCSL
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
ONDS
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
OPI
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
OPRT
TickerGrove reporting and official SEC filings.
Nasdaq · SEC-verified identity
OPTU
TickerGrove reporting and official SEC filings.
NYSE · SEC-verified identity
Filings and results
Healthcare / M&A
Viatris will pay $36.50 a share in cash — about 45% above Wednesday's close — for the maker of Exparel and Zilretta, assembling a non-opioid pain franchise ahead of a December FDA decision on its meloxicam candidate.
Companies
An independent committee concluded the Phase 3 UNITY study could not meet its goal. The same day, a celiac disease drug the company bought in August succeeded in a mid-stage trial.
Markets / AI Financing
Apollo and Blackstone are among the lenders Broadcom has approached to fund its OpenAI chip collaboration; Oracle is in talks with Apollo and Goldman Sachs on a large chip purchase — the AI buildout is outgrowing bonds.
Earnings
Organic sales grew 3.1%, the fastest since late 2023, as international markets rose 8%. But the company now sees core earnings per share up just 1% to 2% at constant currency this year, after pointing to about 4%.
Earnings
Fuel accounted for nearly all of the profit gain at 7-Eleven Inc., while system and advertising costs cut profit in Japan. Holding the forecast points to a weaker second half.
Earnings
Converted at the exchange rate TSMC used in its July forecast, the quarter came in about 2% above the top of the company's range. Profit and margins arrive with full results on Oct. 15.
Build the skill
Company analysis
The income statement records revenue and expenses over a period.
Company analysis
Revenue is the top-line amount recognized from a company’s activities under its accounting policy.
Investing basics
A stock is an ownership interest in one company.